Ex Parte SansoucyDownload PDFPatent Trial and Appeal BoardApr 25, 201813542173 (P.T.A.B. Apr. 25, 2018) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 13/542, 173 07/05/2012 143331 7590 04/27/2018 Medtronic, Inc./RCS Shumaker 60 Middletown A venue c/o Legal - Mailstop MS 54 North Haven, CT 06473 FIRST NAMED INVENTOR Michael Sansoucy UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. H-KN-02304US/1214-097US01 3569 EXAMINER FARRAR, LAUREN PENG ART UNIT PAPER NUMBER 3763 NOTIFICATION DATE DELIVERY MODE 04/27/2018 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address( es): SurgicalUS@covidien.com medtronic_mitg-rcs_docketing@cardinal-ip.com pairdocketing@ssiplaw.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte MICHAEL SANSOUCY Appeal2017-003130 Application 13/542, 173 Technology Center 3700 Before LYNNE H. BROWNE, MICHELLE R. OSINSKI, and PAUL J. KORNICZKY, Administrative Patent Judges. OSINSKI, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Michael Sansoucy ("Appellant") 1 appeals under 35 U.S.C. § 134(a) from the Examiner's decision rejecting claims 1-11 and 13-21. 2 We have jurisdiction under 35 U.S.C. § 6(b ). We AFFIRM-IN-PART. 1 Appellant identifies the real party in interest as "Medtronic plc of Dublin, Ireland, which is the ultimate parent entity of the assignee of record, Covidien LP." Appeal Br. 3. 2 Claim 12 is cancelled. Amendment (Dec. 21, 2015). Appeal2017-003130 Application 13/542, 173 THE CLAIMED SUBJECT MATTER Claims 1, 17, and 21 are independent. Claim 1, reproduced below, is representative of the claimed subject matter on appeal. l, A split-tip catheter comprising: a body defining first and second lumens and first and second separated dista1 tip portions, each of the separated distal tip portions defining a lurnen which communicates with one of the first or second lumens, each of the separated distal tip pmiions including at least one distally located normally closed, one-way valve, each of the distally located one-way valves being configured to open in response to an increase in pressure within a respective one of the first and second 1umens to enable fluid to be discharged from the respective first or second lumen; and at least one proximally 1ocated normally closed, one-way valve associated with each of the first and second lumens, each of the proximally located one-way valves being spaced proximally of the distally located one-way valves and being configured to open in response to a decrease in pressure within a respective one of the first and second lurnens to enable fluid to enter the respective first or second lumen, EVIDENCE The Examiner relied on the following evidence in rejecting the claims on appeal: Dye Spencer Makower Ash Matson Malhi us 3,726,283 us 3,888,249 US 2006/0184089 Al US 2007 /0225682 Al US 2010/0081986 Al US 2013/0085478 Al 2 Apr. 10, 1973 June 10, 1975 Aug. 17, 2006 Sept. 27, 2007 Apr. 1, 2010 Apr. 4, 2013 Appeal2017-003130 Application 13/542, 173 THE REJECTIONS I. Claims 1-5, 8-10, 13-15,3 and 17-21 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Matson, Spencer, and Ash. Final Act. 2--4. II. Claims 6 and 7 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Matson, Spencer, Ash, and Malhi. Id. at 5. III. Claim 11 stands rejected under 35 U.S.C. § 103(a) as unpatentable over Matson, Spencer, Ash, and Makower. Id. IV. Claim 16 stands rejected under 35 U.S.C. § 103(a) as unpatentable over Matson, Spencer, Ash, and Dye. Id. at 5---6. OPINION Rejection I Claims 1-3, 8-10, and 14 Appellant argues claims 1-3, 8-10, and 14 as a group. Appeal Br. 6- 10. We select claim 1 as the representative claim, and claims 2, 3, 8-10, and 14 stand or fall therewith. 37 C.F.R. § 41.37(c)(l)(iv). The Examiner relies on Matson for the limitations of claim 1, except for (i) the body of the catheter defining separated distal tip portions and (ii) each of the separated distal tip portions including at least one distally located one-way valve. Final Act. 2-3. The Examiner relies on Spencer's teaching 3 Even though the Examiner failed to include reference to claims 13 and 14 in the heading for this rejection (see Final Act. 2), the Examiner references claim 13 within the body of the rejection (see id. at 3-4) and finds that rviatson discloses the features of claim 14 (see id. at 6). \Ve consider the Examiner's oversight in the heading to be a typographical eITor, and therefore, we list claims 13 and 14 as being subject to this ground of rejection. Appellant also considers claims 13 and 14 to be subject to this ground of rejection. Appeal Br. 6, 10, 12-14. 3 Appeal2017-003130 Application 13/542, 173 of "distal slit valves (24 )" on an arterial infusion catheter and concludes that it would have been obvious to one of ordinary skill in the art "to modify the device of Matson to include distal valves as taught by Spencer for the purpose of delivering medication out of the catheter." Id. at 2 (citing Spencer col. 2). More particularly, the Examiner determines that "a simple substitution to have an alternate means of delivery medication out of a catheter would be within the skill of one of ordinary skill in the art." Ans. 2. Alternatively, the Examiner points to Spencer's teaching that distal valves "provide uniformity and improved diffusion into the bloodstream" and concludes that "[t]herefore, there is direct motivation ... for having the distal valves [of Spencer] in combination with the device of Matson." Id. (citing Spencer 2:50-52). The Examiner relies on Ash's teaching of "separated tip portions" and reasons that it would have been obvious to one of ordinary skill in the art "to modify the device of [Matson ]/Spencer with the separated distal tip portions as taught by Ash for the purpose of allowing the two lumens to be operated independently of one another." Final Act. 3 (citing Ash Fig. 17, i-f 16). The Examiner further finds that "it would ... be within the skill of one of ordinary skill in the art to look to the split distal ends as a substitute configuration for the two lumens" and "the separated distal tip portions of Ash proves the ability for the user to manipulate ... the two lumens individually[,] thus allowing for greater flexibility." Id. at 6. With respect to the modification based on the teachings of Spencer, Appellant argues that "the Examiner has not shown that Matson' s openings 84, 86 and openings with Spencer's 'distal valves' provide the same function 4 Appeal2017-003130 Application 13/542, 173 or serve the same purpose." Reply Br. 3 (footnote omitted). Appellant, thus, asserts that the Examiner's reliance on the "simple substitution" rationale is in error, at least because the Examiner has not shown that "all the claimed elements were known in the prior art and one skilled in the art could have combined the elements as claimed by known methods with no change in their respective functions, and the combination yielded nothing more than predictable results to one of ordinary skill in the art." Id. at 4 (citing Manual of Patent Examining Procedure (MPEP) § 2143(I)(A)). We are not persuaded of error by the Examiner in that a rationale based on simple substitution does not require that there be no change in the function of the substituted element, but rather that "the substituted components and their functions were known in the art" and that "the results of the substitution [of one known element for another] would have been predictable." MPEP § 2143(I)(B); see also KSR Int'! Co. v. Teleflex Inc., 550 U.S. 398, 416 (2007) (recognizing "that when a patent claims a structure already known in the prior art that is altered by the mere substitution of one element for another known in the field, the combination must do more than yield a predictable result"). Here, Appellant has not persuaded us that the function of distal valves as taught by Spencer were unknown in the art or that the Examiner's proposed substitution would yield more than predictable results to the ordinary artisan. Appellant also argues that "the Examiner has not established that a person having ordinary skill in the art would have understood the device of Matson to have suffered from a lack of uniformity or poor diffusion of medication delivered through the device of Matson." Reply Br. 4. Appellant seems to be arguing that in order for the proposed combination to 5 Appeal2017-003130 Application 13/542, 173 be proper, Matson must disclose a need for the proposed modification or must disclose that a certain improvement would be advantageous. We do not agree. The Supreme Court has rejected the rigid requirement of demonstrating a teaching, suggestion, or motivation to combine known elements in order to show obviousness. KSR, 550 U.S. at 419. Rather, rejections based on obviousness must be supported by "some articulated reasoning with some rational underpinning" to combine known elements in the manner required by the claim. Id. at 418 (citing In re Kahn, 441 F.3d 977, 988 (Fed. Cir. 2006)). As described above, the evidence before us shows that distal valves were known in the art, and the Examiner's proposed modification to replace open ends with distal valves does not appear to amount to "more than the simple substitution of one known element for another" and is therefore obvious. KSR, 550 U.S. at 417 (internal citation omitted). Appellant additionally argues that the Examiner has not shown that Spencer's distal valves (i) would provide more uniformity and improved diffusion relative to Matson's openings 84, 86 specifically and (ii) would not frustrate the principle of operation of Matson's catheter by failing to permit fluid flow to the same extent as Matson's openings 84, 86. Reply Br. 4--5. For the same reasons described above, we remain unpersuaded that the Examiner's articulated reasoning in support of the conclusion of obviousness-simple substitution of one known element for another-lacks rational underpinnings. Although tradeoffs may be required in balancing the benefits and drawbacks of distal valves in place of open end arrangements, such tradeoffs do not necessarily prevent the proposed combination or negate the obviousness of the claimed subject matter. See 6 Appeal2017-003130 Application 13/542, 173 Rolabo, S.L., 437 F.3d 1157, 1165 (Fed. Cir. 2006) ("a given course of action often has simultaneous advantages and disadvantages, and this does not necessarily obviate motivation to combine"). With respect to the modification of Matson/Spencer based on the teachings of Ash, Appellant argues that "[b ]ecause Matson already describes independent operation as defined by the Examiner [e.g., separated fluid flow (Ans. 2)], a person having ordinary skill in the art would not have looked to Ash to solve the purported problem of independent operation." Reply Br. 6. Appellant, however, does not point out any flaw in the Examiner's reasoning relating to individual manipulation of the two lumens for greater flexibility (Final Act. 6), which is distinguishable from mere individual operation. As to Appellant's additional argument that Ash's catheter does not include openings that are both opposed and "arranged in a diametrical fashion" (Reply Br. 7), we are not persuaded of Examiner error in that the Examiner's rejection is not based on bodily incorporation of Ash's catheter into the Matson/Spencer catheter, but rather based on modifying the device of Matson/Spencer so as to have separated distal tip portions. See In re Keller, 642 F.2d 413, 425 (CCPA 1981) (citations omitted) ("The test for obviousness is not whether the features of a secondary reference may be bodily incorporated into the structure of the primary reference. . . . Rather, the test is what the combined teachings of the references would have suggested to those of ordinary skill in the art."). Appellant does not persuade us that the Examiner's modification of Matson/Spencer with Ash's teachings would result in openings that are "simply opposed," but not "diametrically opposed." Reply Br. 7. As acknowledged by Appellant, Matson already teaches openings or ports that are diametrically opposed to 7 Appeal2017-003130 Application 13/542, 173 each other (Appeal Br. 8-9), and modification so as to provide separated distal tips will not prevent the diametrical opposition of Matson' s tips. For the foregoing reasons, we do not find that the Examiner erred in concluding that the subject matter of independent claim 1 is rendered obvious by Matson, Spencer, and Ash. We sustain the rejection of claim 1, and claims 2, 3, 8-10, and 14 falling therewith, under 35 U.S.C. § 103(a) as unpatentable over Matson, Spencer, and Ash. Claim 4 Claim 4 recites that the catheter "further compris[ es] a support structure formed in the body adjacent at least one of the proximally located, one-way valves." Appeal Br. 22 (Claims App.). The Examiner determines that "any of the catheter body [of Matson] located adjacent the slit could be considered a support structure." Final Act. 3. Based on this determination, the Examiner finds that Matson discloses a "support structure formed in the body adjacent at least one of the proximally located, one-way valves," as claimed. Id. Appellant argues that "the Examiner has not ... identified any structure adjacent the adjacent inner portion 62 of Matson's catheter member that would be reasonably understood by a person having ordinary skill in the art to have been a support structure." Appeal Br. 10. To construe the limitation of a "support structure" of a catheter as merely any portion of the catheter body would effectively render the claim limitation superfluous, and thus would be improper. See Stumbo v. Eastman Outdoors, Inc., 508 F .3d 1358, 1362 (Fed. Cir. 2007) (denouncing claim constructions which render phrases in claims superfluous). That is, under the Examiner's interpretation, the claim limitation is construed so broadly that every catheter would have a 8 Appeal2017-003130 Application 13/542, 173 support structure by virtue of it having a catheter body, whereas Appellant takes the position this would be unreasonable. Although we appreciate the Examiner's statement that "[t]here is not additional structure defining the support" (Ans. 3), the term "support structure" must be construed in a way that gives the term effect. Merely selecting any portion of the catheter body as a "support structure" fails to give the term any effect, because every catheter would have a catheter body. Therefore, the Examiner's position fails to give proper weight to the limitation of claim 4. For the foregoing reasons, we find that the Examiner erred in concluding that the subject matter of claim 4 is rendered obvious by Matson, Spencer, and Ash. We do not sustain the rejection of claim 4 under 35 U.S.C. § 103(a) as unpatentable over Matson, Spencer, and Ash. Claim 5 Claim 5 recites that "each of the proximally located one-way valves includes tapered inwardly deformable flaps." Appeal Br. 23 (Claims App.). The Examiner finds that "Matson discloses wherein each of the proximally located one-way valves includes tapered inwardly deformable flaps (see element 9[4] in Fig. 12)." Final Act. 3. More particularly, the Examiner states "the claim was interpreted to read that the flap would taper inwardly" and that "when ... flap 94 is opened[,] the flap is pushed inwardly[,] thereby creating a taper inward toward the center of the catheter body." Ans. 3. The Examiner continues that "[t]he claims as currently recited do not prevent such an interpretation" and that "[ fJurther limitations regarding the actual flap being tapered itself would be needed to overcome the current rejection." Id. 9 Appeal2017-003130 Application 13/542, 173 Appellant argues that "the Examiner appears to interpret any flap that is pushed inwards as being a tapered flap" and "fail[ s] to give claim 5 the 'broadest reasonable interpretation consistent with the specification."' Reply Br. 10 (emphasis and citation omitted). The Specification refers to "proximal one-way slit valves 220 ... includ[ing] tapered inwardly deformable flaps 220a" and subsequently states that "the slits are defined by the tapered flaps 220a." Spec. i-f 58; see also id. Fig. 5A. We agree with Appellant that, under a broadest reasonable interpretation consistent with the Specification, the claim would be interpreted as requiring the flaps themselves to be tapered, not merely that they be capable of being pushed inward toward the center of the catheter body. The Examiner's finding that Matson discloses that "each of the proximally located one-way valves includes tapered inwardly deformable flaps," as recited in claim 5 (Final Act. 3) is not adequately supported by the reference when this claim language is given its broadest reasonable interpretation in light of the Specification. For the foregoing reasons, we find that the Examiner erred in concluding that the subject matter of claim 5 is rendered obvious by Matson, Spencer, and Ash. We do not sustain the rejection of claim 5 under 35 U.S.C. § 103(a) as unpatentable over Matson, Spencer, and Ash. Claim 13 Claim 13 recites that "each of the separated tip portions include at least one of the proximally located one-way valves." Appeal Br. 23 (Claims App.). The Examiner states in the Answer that "Matson already teaches proximal one way valves" and that "Ash is simply used to show that each separated distal tip[] can contain multiple one way valves on the outer 10 Appeal2017-003130 Application 13/542, 173 body." Ans. 3--4. Accordingly, we understand the Examiner to be explaining why the proposed modification to the Matson/Spencer device so as to have separated tips would result in both Matson's proximally located one-way valves and Matson's distally located one-way valves being on separated tip portions. Appellant acknowledges that Ash shows two valves 616 "as shown by the lead lines in FIG. 17." Reply Br. 12. Even if "neither of the two valves 616 shown in FIG. 17 are distal or proximal with respect to each other" as asserted by Appellant (id.), we do not view the Examiner's rejection as hinging on a characterization of valves 616 as distal and proximal relative to each other. Rather, we view the Examiner as relying on Ash for the concept of having multiple valves on a separated distal tip, in support of the Examiner's conclusion that one of ordinary skill in the art would separate the tip of the Matson/Spencer device in a way so that each of the separated tip portions include at least one of the proximally located one-way valves 94 of Matson, as well as the distally located one-way valves of Matson/Spencer. For the foregoing reasons, we do not find that the Examiner erred in concluding that the subject matter of claim 13 is rendered obvious by Matson, Spencer, and Ash. We sustain the rejection of claim 13 under 35 U.S.C. § 103(a) as unpatentable over Matson, Spencer, and Ash. Claim 15 Claim 15 recites that each of the proximally located one-way valves includes a membrane supported within the respective one of the first and second lumens of the body, the membrane being positioned to cover a throughbore formed in the body and being inwardly movable to enable fluid to enter the throughbore, at least a portion of the membrane being secured to the body. 11 Appeal2017-003130 Application 13/542, 173 Appeal Br. 24 (Claims App.). The Examiner finds that Matson's element 94 meets these claims limitations (Final Act. 4 (citing Matson Fig. 12) ), explaining that "a membrane is simply interpreted as a thin piece of material" and "flap portion 94 of Matson could be considered a membrane" (Ans. 4). Appellant argues that "Matson nowhere describes or suggests that valve member 94 is or includes a membrane, or otherwise functions like a membrane." Appeal Br. 14--15. Appellant has not persuaded us that the Examiner's interpretation of a membrane is unreasonable, and, thus, Appellant has not persuaded us that the Examiner's finding that Matson's element 94 constitutes a membrane is not supported by a preponderance of the evidence. For the foregoing reasons, we do not find that the Examiner erred in concluding that the subject matter of claim 15 is rendered obvious by Matson, Spencer, and Ash. We sustain the rejection of claim 15 under 35 U.S.C. § 103(a) as unpatentable over Matson, Spencer, and Ash. Claims 17-21 In contesting the rejection of claims 17-21, Appellant relies on the same arguments and reasoning we found unpersuasive in connection with independent claim 1. See Appeal Br. 16-17. Accordingly, we also sustain the rejection of claims 17-21 under 35 U.S.C. § 103(a) as unpatentable over Matson, Spencer, and Ash. Rejections 11-111 The Examiner rejects, under 35 U.S.C. § 103(a), claims 6 and 7 as unpatentable over Matson, Spencer, Ash, and Malhi, and claim 11 as unpatentable over Matson, Spencer, Ash, and Makower. Final Act. 5. In 12 Appeal2017-003130 Application 13/542, 173 addition to relying on the same arguments and reasoning we found unpersuasive in connection with independent claim 1 (Appeal Br. 17-19), Appellant argues that Matson, Spencer, Ash, and Malhi "fails to disclose or suggest a split-tip catheter 'wherein each of the proximally located one-way valves includes a slit which extends through the body and a concavity formed about the slit,' as recited by claim 6" (id. at 17) and that Matson, Spencer, Ash, and Makower "fails to disclose or suggest a split-tip catheter 'wherein each of the proximally located one-way valves is a duckbill valve,' as recited by claim 11" (id. at 18). The additional arguments amount to the recitation of the claim elements and a "naked assertion" that the elements are not in the prior art. Such reasoning is not persuasive. See 37 C.F.R. § 41.37(c)(l)(iv); In re Lovin, 652 F.3d 1349, 1357 (Fed. Cir 2011) (holding that the Board had reasonably interpreted the same language in the prior rule under 3 7 C.F .R. § 41.3 7 ( c )( 1 )(vii) as requiring "more substantive arguments in an appeal brief than a mere recitation of the claim elements and a naked assertion that the corresponding elements were not found in the prior art"). For the foregoing reasons, we do not find that the Examiner erred in concluding that the subject matter of claims 6, 7, and 11 is rendered obvious. We sustain the rejection, under 35 U.S.C. § 103(a), of claims 6 and 7 as unpatentable over Matson, Spencer, Ash, and Malhi and claim 11 as unpatentable over Matson, Spencer, Ash, and Makower. Rejection IV Claim 16 recites that the catheter "further includ[ es] a support rib extending across the throughbore, the support rib being positioned to prevent outward movement of the membrane." Appeal Br. 24 (Claims App.). The Examiner determines that although "Matson/Spencer/ Ash teaches a 13 Appeal2017-003130 Application 13/542, 173 through[]bore, ... [it] does not teach a support rib." Final Act. 6. The Examiner finds that "Dye teaches a support rib (see portion of lumen that abuts the end of the flap valve (501 in Fig. 8) extending across the through[]bore[,] the support rib being positioned to prevent outward movement of the membrane." Id. The Examiner reasons that it would have been obvious "to modify the device of Matson/Spencer/ Ash with the support rib as taught by Dye for the purpose of preventing outward movement of the membrane in order to seal the opening when pressure is applied to the lumen." Id. (citing Dye 5:9-45). In addition to relying on the same arguments and reasoning we found unpersuasive in connection with independent claim 1 (Appeal Br. 20), Appellant argues that "the Examiner failed to establish a person having ordinary skill in the art would have understood the portion of the drainage lumen 420 of Dye characterized by the Examiner as being 'a support rib extending across [a] throughbore,' a recited by claim 16" (Reply Br. 14 ). Appellant does not adequately explain how the Matson/Spencer/ Ash device, as modified by Dye, would fail to include a portion that extends across the throughbore in at least one direction (i.e., in the same direction as the proximal edge of Matson's flap 94 engaging with the portion of the catheter when in a closed position). Having the portion extend across the throughbore just as the proximal edge of Matson's flap 94 extends across the throughbore prevents outward movement of flap 94 in accordance with the Examiner's articulated rationale. For the foregoing reasons, we do not find that the Examiner erred in concluding that the subject matter of claim 16 is rendered obvious by 14 Appeal2017-003130 Application 13/542, 173 Matson, Spencer, Ash, and Dye. We sustain the rejection of claim 16 under 35 U.S.C. § 103(a) as unpatentable over Matson, Spencer, Ash, and Dye. DECISION The Examiner's decision to reject claims 1-3, 8-10, 13-15, and 17- 21under35 U.S.C. § 103(a) as unpatentable over Matson, Spencer, and Ash is affirmed. The Examiner's decision to reject claims 4 and 5 under 35 U.S.C. § 103(a) as unpatentable over Matson, Spencer, and Ash is reversed. The Examiner's decision to reject claims 6 and 7 under 35 U.S.C. § 103(a) as unpatentable over Matson, Spencer, Ash, and Malhi is affirmed. The Examiner's decision to reject claim 11 under 35 U.S.C. § 103(a) as unpatentable over Matson, Spencer, Ash, and Makower is affirmed. The Examiner's decision to reject claim 16 under 35 U.S.C. § 103(a) as unpatentable over Matson, Spencer, Ash, and Dye is affirmed. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a)(l )(iv). AFFIRMED-IN-PART 15 Copy with citationCopy as parenthetical citation